Gallic Acid

Medchemexpress LLC Ethanone, 1-(2-pyridinyl)-, 2-(6-methyl-5H-1,2,4-triazino[5,6-b]indol-3-yl)hydrazone | 327031-55-0 | MFCD01305422 | 99.8% | 317.35 g/mol | C17H15N7 | 50MG

VLX600 is a small-molecule iron-chelating inhibitor of oxidative phosphorylation that disrupts mitochondrial function, shifts metabolism toward glycolysis, and exhibits selective cytotoxicity against malignant and quiescent cancer cells. It is supplied as a research-grade powder for preclinical biochemical and cellular studies; follow recommended storage and handling.

• Iron-chelating inhibitor of oxidative phosphorylation and modulator of mitochondrial metabolism.
• Selective cytotoxicity against quiescent and malignant cancer cells in preclinical studies.
• High purity (99.8%) appropriate for research-grade assays.
• Supplied as a powder; recommended cold storage to preserve stability.
• Chemical formula C17H15N7 and molecular weight 317.35 g/mol.

Medchemexpress LLC Vlx600 | 327031-55-0 | MFCD01305422 | 99.8% | 317.35 | C17H15N7 | 100MG

VLX600 is a small-molecule oxidative phosphorylation (OxPhos) inhibitor and iron chelator used in cancer and mitochondrial metabolism research. It impairs mitochondrial respiration, induces autophagy, and shows selective cytotoxicity in quiescent or nutrient-starved tumor cells. Molecular formula C17H15N7; molecular weight 317.35; CAS 327031-55-0.

• Inhibits mitochondrial oxidative phosphorylation.
• Functions as an iron chelator.
• Induces autophagy and promotes tumor cell death under nutrient limitation.
• Useful as a reference compound for cancer metabolism studies.
• Crystalline solid with reported DMSO solubility around 25 mg/mL.
• Recommended storage at -20°C as a powder.

Medchemexpress LLC Ethanone, 1-(2-pyridinyl)-, 2-(6-methyl-5H-1,2,4-triazino[5,6-b]indol-3-yl)hydrazone | 327031-55-0 | MFCD01305422 | 99.8% | 317.35 g/mol | C17H15N7 | 10MG

VLX600 is an iron-chelating inhibitor of oxidative phosphorylation used as a research tool to induce mitochondrial dysfunction, shift cellular metabolism toward glycolysis, and trigger autophagy and selective cytotoxicity in malignant cells. It is supplied for research use and is characterized by CAS 327031-55-0, molecular formula C17H15N7, and molecular weight 317.35 g/mol.

• Iron-chelating inhibitor of oxidative phosphorylation that disrupts mitochondrial function.
• Induces a metabolic shift toward glycolysis in treated cells.
• Promotes autophagy and selective cytotoxicity in malignant or quiescent cancer cells.
• High chemical purity, typically 99.8%.
• Supplied in small pack sizes suitable for in vitro research (for example, 10 mg).

Medchemexpress LLC Vlx600 | 327031-55-0 | MFCD01305422 | 99.8% | 317.35 g·mol⁻¹ | C17H15N7 | 5MG

VLX600 is a small-molecule research compound that acts as an iron-chelating inhibitor of oxidative phosphorylation (OXPHOS). It induces mitochondrial dysfunction, shifts cells toward glycolysis, and shows selective cytotoxicity against quiescent cancer cells. The material is supplied as a light yellow solid with high purity for laboratory research.

• Iron-chelating inhibitor of oxidative phosphorylation.
• Selective cytotoxicity toward quiescent cancer cells.
• High purity: 99.8%.
• Molecular formula C17H15N7; molecular weight 317.35 g·mol⁻¹.
• Light yellow solid appearance.
• Stable as powder: store at -20°C for long term or 4°C for short term.
• Available in small research pack sizes starting at 5 mg.